Merck & Co., Inc.MRKNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+13.6%
5Y CAGR+37.0%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+13.6%/yr
vs +19.6%/yr prior
5Y CAGR
+37.0%/yr
Recent deceleration
Acceleration
-6.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $26.78B | +32.4% |
| 2024 | $20.22B | +584.5% |
| 2023 | $2.95B | -83.8% |
| 2022 | $18.28B | +38.5% |
| 2021 | $13.20B | +137.9% |
| 2020 | $5.55B | -30.0% |
| 2019 | $7.93B | -11.3% |
| 2018 | $8.93B | +31.4% |
| 2017 | $6.80B | +23.6% |
| 2016 | $5.50B | - |